Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
grade B 5.68 4.60% 0.25
VNRX closed up 4.6 percent on Friday, October 18, 2019, on 79 percent of normal volume.

Earnings due: Nov 5

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VNRX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Narrow Range Bar Range Contraction 4.60%
NR7 Range Contraction 4.60%
Inside Day Range Contraction 4.60%
Up 3 Days in a Row Strength 4.60%
Shooting Star Candlestick Bearish 5.19%
Narrow Range Bar Range Contraction 5.19%
Doji - Bearish? Reversal 5.19%

Older signals for VNRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Cancer Biology Diseases Disease Molecular Biology Epigenetics
Is VNRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.84
52 Week Low 1.67
Average Volume 240,983
200-Day Moving Average 3.4943
50-Day Moving Average 4.5452
20-Day Moving Average 5.423
10-Day Moving Average 5.357
Average True Range 0.4065
ADX 28.0
+DI 27.8885
-DI 14.2114
Chandelier Exit (Long, 3 ATRs ) 5.6205
Chandelier Exit (Short, 3 ATRs ) 5.4095
Upper Bollinger Band 6.1226
Lower Bollinger Band 4.7234
Percent B (%b) 0.68
BandWidth 25.801217
MACD Line 0.2525
MACD Signal Line 0.2851
MACD Histogram -0.0326
Fundamentals Value
Market Cap 150.62 Million
Num Shares 26.5 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -10.92
Price-to-Sales 0.00
Price-to-Book 3.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.25
Resistance 3 (R3) 6.23 6.01 6.16
Resistance 2 (R2) 6.01 5.87 6.03 6.12
Resistance 1 (R1) 5.85 5.78 5.93 5.87 6.09
Pivot Point 5.63 5.63 5.68 5.65 5.63
Support 1 (S1) 5.47 5.49 5.55 5.49 5.27
Support 2 (S2) 5.25 5.40 5.27 5.24
Support 3 (S3) 5.09 5.25 5.21
Support 4 (S4) 5.11